康科特 6518.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 6518)
6518 Value Score
3
24
15
Good Growth
- AI analysis rates 6518 with a higher value score of 4.
- It is mainly due to adequate operating cash flow, along with adequate saety shown in the balance sheet.
- Over the past 3 months, 6518 has maintained a consecutive value rating of 4.0, slightly lower than the rating of 4.9 over the past 3 years, indicating decreasing growth opportunities for enterprise value.
- Compared to all stocks in the Biotech. & Medical sector, 6518 has a medium value rating.
6518 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/07 (Weekly Update)
6518 Financial Forecast
Unit : TWD
Update to 2025/5/13 (Quarterly Update)
6518 Earnings Table
No related data records
6518 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
6518 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 6518 from 2015/05 till Now
- 111.02%
- Cumulative Return
- 8.03%
- Annual Return
- 35.55%
- Volatility
- 0.23
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from May, 2015 to May, 2025. (Total Trades: 1)
| 6518 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | 100% | 46% | 53% |
| Avg Return | 111% | 21.1% | 45.4% |
| Avg Profit | 111% | 72.2% | 102.9% |
| Avg Loss | - | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | - | 322.8% | 505.8% |
Update to 2025/5/14 (Daily Update)